Success Stories: EB-1A Approved for a Senior Scientist from India With the Help of Our Supporting Team

Client’s Testimonial:

“I sincerely appreciate your efforts and support with my EB1A application.”

On October 2^nd, 2020, we received another EB-1A (Alien of Extraordinary Ability) approval for a Senior Scientist in the Field of Pharmaceutical Sciences (Approval Notice).

General Field: Pharmaceutical Sciences

Position at the Time of Case Filing: Senior Scientist

Country of Origin: India

State of Residence at the Time of Filing: Pennsylvania

Approval Notice Date: October 2^nd, 2020

Processing Time: 7 months, 10 days

Case Summary:

A senior scientist from India, holding a Ph.D. in pharmaceutical sciences engaged us to compose an EB-1A (Alien of Extraordinary Ability) petition on his behalf. As a part of our legal strategy, we asked him to provide us with the required relevant documents to get him to achieve the EB1A approval. Based on the wealth of information we gathered, we determined our client’s research background, expertise field, and further achievements, confirming his extraordinary ability to continue his research work here in the U.S. Thus, we counter-signed the attorney-client agreement and prepared our client’s petition letter highlighting his extraordinary ability in the field.

We described his research on the use of lipid-based drug delivery systems and solid dispersions to develop novel pharmaceutical products and how it addresses some of our nation’s most pressing issues in understanding the successful methods for administering soluble and effective drugs for various prominent healthcare conditions.
Also, we noted the 10 peer-reviewed scientific articles published by him in some of the impacting journals in his field. We observed that he not only conducted important original research but his work is also considered crucially significant by the editors of the top journals in the field. Further, we recorded that he is an active peer-reviewed in the scientific community for prestigious journals, and he has already conducted 22 reviews.
In addition, we detailed the 152 citations his work amassed at the time of filing, and his article citation rates are between 2.18 and 16.67 times higher than the average number of citations in the field for their respective publication years, distinguishing him from other researchers in the field.
Moreover, we attached five recommendation letters in his case to support the petition further. The letters were acquired by our client from fellow experts in the field, asserting our client’s expertise and experience in contributing significantly to the field of pharmaceutical sciences here in the U.S. One of the recommenders remarked:

“[Client’s] tremendous work with drug delivery systems has substantially bolstered scientific understanding and established novel avenues for further research to improve pharmaceutical interventions for patients worldwide…The record of his achievement shows him to be an elite researcher ready to continue shaping scholarship…”

We successfully convinced the USCIS that our client is an asset to the United States, hence our client achieved his EB-1A approval drawing him one step closer to obtaining a green card. We thank him for letting us represent his EB-1A application and be a part of this success story.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.